Page last updated: 2024-09-05

erlotinib hydrochloride and Bronchopulmonary Dysplasia

erlotinib hydrochloride has been researched along with Bronchopulmonary Dysplasia in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
He, H; Li, J; Li, W; Li, Y; Liu, C; Xie, L; Zhang, Y1

Other Studies

1 other study(ies) available for erlotinib hydrochloride and Bronchopulmonary Dysplasia

ArticleYear
Csk/Src/EGFR signaling regulates migration of myofibroblasts and alveolarization.
    American journal of physiology. Lung cellular and molecular physiology, 2016, Mar-15, Volume: 310, Issue:6

    Topics: Animals; Bronchopulmonary Dysplasia; Cell Movement; CSK Tyrosine-Protein Kinase; ErbB Receptors; Erlotinib Hydrochloride; Female; Lipopolysaccharides; Myofibroblasts; Pulmonary Alveoli; Rats, Sprague-Dawley; rhoA GTP-Binding Protein; Signal Transduction; src-Family Kinases

2016